Publication | Closed Access

Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel

NanoparticlesNanomedicineEngineeringPolymer-drug ConjugateHuman Serum AlbuminBiological EvaluationNano-drug DeliveryBiomedical EngineeringTumor TargetingDrug Delivery SystemPharmacology